Health
Karnataka health dept to monitor cancer patients after fake drug bust
Reported by Kavya Rao (Senior Writer) · The Hindu - Health ·
Reported by one source so far
Representative image · PexelsKarnataka health officials will begin tracking cancer patients after a major seizure of counterfeit medicines. ## Patient Tracking Officials will check records of cancer patients in private hospitals and call them to verify health status, noting some may have unknowingly bought fake drugs. ## Reference Standards The department wrote to Pfizer asking for its reference standards so labs can differentiate fake from genuine drugs; Pfizer has not replied, leading to a request to the Union government for assistance. ## Legal Action Licences of 16 retail and wholesale pharmaceutical firms were cancelled and eight were suspended. The department is considering filing cases against manufacturers, distributors and shop owners under Section 105 of the Bharatiya Nyaya Sanhita, which carries life imprisonment or five‑to‑ten years for intent to cause death or serious injury. ## Upcoming Conclave An all‑India health conclave will be held in Bengaluru in the third week of October, bringing together health ministers, FSDA and FSSAI officials and other stakeholders to decide strong actions against counterfeit drugs.
ExplainerWhy this matters
What Happened
Karnataka seized a large batch of counterfeit medicines used for cancer treatment and decided to track affected patients.
Why It Matters
Tracking helps identify patients who may have received ineffective or harmful drugs, allowing timely medical intervention. Access to Pfizer's reference standards would let labs quickly spot fakes, improving safety. The legal action under Section 105 signals serious intent to deter producers and sellers, protecting public health.
What Happens Next
The health department will contact private hospitals, gather patient data and monitor outcomes. It will follow up with Pfizer and the Union government for reference standards. Pending the outcome of investigations, cases may be filed under the Bharatiya Nyaya Sanhita. The upcoming health conclave in Bengaluru will review progress and may issue nationwide guidelines to curb counterfeit drugs.
